On the evening of October 11, Qingdao Jianma Gene Technology Co., Ltd. (hereinafter referred to as "Jianma Gene "), a wholly-owned subsidiary of Qingdao nede Biotechnology Co., Ltd. (Stock Code: 800757), which was listed in Qingdao blue ocean equity trading center, received the product demand of Qingdao virus sampling tube. The enterprise immediately integrated resources of all parties and put it into "combat" state in less than 20 hours Nearly 100000 virus sampling tubes were provided. The virus sampling tube meets the requirements of the State Council's new coronavirus nucleic acid 10 in 1 mixed collection and detection technical specification, and can be used for nucleic acid detection of nearly one million people, which maximizes the detection efficiency and helps Qingdao to fight against "epidemic" through science and technology.
Disposable virus sampling tube set provided by Jianma Gene
"At present, the whole city is tense, and Qingdao urgently mobilizes resources from the whole country. As a local enterprise in Qingdao, it is our bounden duty to fully support the fight against the epidemic. " Dong Xuefeng, general manager of Jianma Gene, said that since receiving the urgent demand from multiple sampling pipes, the company mobilized personnel, materials and other resources all night to quickly put into the production and supply process of overtime. The whole staff and raw materials are in place as soon as possible. It only takes less than 20 hours from receiving the notice to the completion of the project. After the products are ready, they are sent to the first-line sampling points in batches for use.
The virus sampling tube produced by Jianma Gene was used in a detection point
After collecting nasopharyngeal swabs at each detection point, the swabs were placed in the virus preservation tube and transported to the detection institution for nucleic acid extraction and amplification detection. A disposable virus Jianma Gene was developed in the early stage of the epidemic in China, which can quickly inactivate the active virus that may exist in the nasal / pharyngeal swab samples, and has obtained a class of medical device record and production license. The rapid extraction reagent with the functions of Jianma Gene, virus inactivation and nucleic acid cleavage is developed simultaneously, which can avoid the secondary pollution caused by capping. The product is easy to operate, and the swab is directly put into the reagent after sampling, without additional nucleic acid extraction operation. The sample is processed in 3 minutes. The processed sample DNA / RNA can be directly used in RT-PCR and ASEA and other nucleic acid amplification technologies independently developed by the enterprise, which is conducive to the on-site use of emergency detection and rapid feedback of test results.
In addition to the virus sampling tube used in the whole staff detection, Jianma Gene successfully developed the new coronavirus nucleic acid detection kit in February this year, which can realize the amplification detection of new coronavirus in 30 minutes. It is also one of the few enterprises in the world that can complete amplification detection in half an hour.
Nucleic acid rapid detection expert
Email: navid@naidesw.com
Tel: 0532-88330805
Post time: Nov-11-2020
